In this video

Share

Gilead's Remdesivir reduced risk of hospitalization in high-risk patients

CNBC's Meg Tirrell reports on Gilead's Remdesivir drug and new findings on the drug's effectiveness on high-risk patients.
02:02
Wed, Sep 22 20219:21 AM EDT